Junlin Wang

Mr. Wang is a co-founder of Ranok Therapeutics and also Chairman and CEO of Shanghai UNIONLAB Co. Ltd., a rapidly growing oncology-focused clinical CRO in China. Prior to this, he was President and CEO of Shanghai CP Guojian Pharmaceutical Company. Under his leadership, CP Guojian grew to be one of China’s leading developers of biosimilars, with multiple marketed drugs. Previously, he was Deputy General Manager of Lansheng Guojian Pharmaceutical Company and a Manager at Lansheng CNSK Venture Capital. Mr. Wang is a graduate of Fudan University and received his M.Sc. degree in Professional Accounting from Chinese University of Hong Kong.